Compare BWA & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWA | TECH |
|---|---|---|
| Founded | 1987 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 11.4B |
| IPO Year | 1995 | 1995 |
| Metric | BWA | TECH |
|---|---|---|
| Price | $61.09 | $72.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 11 |
| Target Price | $59.33 | ★ $71.82 |
| AVG Volume (30 Days) | 1.9M | ★ 2.7M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.25% | 0.62% |
| EPS Growth | N/A | ★ 152.17 |
| EPS | ★ 2.50 | 1.16 |
| Revenue | ★ $14,316,000,000.00 | $1,215,039,000.00 |
| Revenue This Year | $1.54 | $2.49 |
| Revenue Next Year | $3.54 | $6.40 |
| P/E Ratio | ★ $24.28 | $62.43 |
| Revenue Growth | ★ 1.63 | N/A |
| 52 Week Low | $40.50 | $43.20 |
| 52 Week High | $78.82 | $72.69 |
| Indicator | BWA | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 41.16 | 56.67 |
| Support Level | $60.08 | $72.11 |
| Resistance Level | $66.46 | $72.66 |
| Average True Range (ATR) | 1.83 | 0.17 |
| MACD | -0.30 | -0.05 |
| Stochastic Oscillator | 29.00 | 54.92 |
BorgWarner is a tier one supplier of turbo and thermal management technologies, drivetrain systems, powerdrive systems, and battery and charging systems mostly to automotive original equipment manufacturers. Its products aim to move a vehicle with as few electrons as possible, resulting in cleaner, cost-optimized, and more-efficient vehicles. Foundational products, the combustion vehicle business, contributes more than 80% to group revenue while BorgWarner transitions to becoming an electric vehicle-centric (e-business) and data center energy management parts supplier. In 2024, 23% of the company's revenue was sourced from Volkswagen and Ford. Revenue is well diversified geographically, with approximately a third each generated in North America, Europe, and Asia.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.